ClinicalTrials.Veeva

Menu

Alpha-linolenic Acid and the Risk of ASCVD

A

Aalborg University Hospital

Status

Completed

Conditions

Ischemic Stroke
Peripheral Artery Disease
Acute Myocardial Infarction

Treatments

Other: Alpha-linolenic acid

Study type

Observational

Funder types

Other

Identifiers

NCT03258983
17-R115-A7415-22060 - 2016-229

Details and patient eligibility

About

Background: The plant-derived omega-3 fatty acid alpha-linolenic acid (ALA, 18:3-n-3) may reduce the risk of atherosclerotic cardiovascular disease, including incident myocardial infarction, ischemic stroke and peripheral artery disease. However, the results of previous studies have been inconsistent.

Objectives: To investigate the associations between dietary intake of ALA, adipose tissue content of ALA, and the risk of the major atherosclerotic cardiovascular diseases incident myocardial infarction, ischemic stroke and subtypes, and peripheral artery disease.

Methods: This project will be based on data from the Danish cohort study Diet, Cancer and Health which consisted of 57,053 men and women at recruitment between 1993 and 1997. Dietary intake of ALA will be assessed using a validated semiquantitative food-frequency questionnaire and adipose tissue content will be determined with the use of gas chromatography analyses of adipose tissue biopsies collected at baseline. Also, detailed information on lifestyle factors, medical history and anthropometri was collected at baseline.

Incident cases have been identified through national registries and the diagnoses have previously been validated.

Analyses of dietary intake of ALA will be analysed using a traditional cohort design, whereas analyses on adipose tissue content of ALA will be analysed based on a case-cohort design. Hazard ratioes with 95% confidence intervals will be used to describe the associations between the exposure variables and the outcome variables of interest.

Enrollment

57,053 patients

Sex

All

Ages

50 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Born in Denmark
  • Age between 50 and 64 years
  • Living in the areas of Copenhagen and Aarhus

Exclusion criteria

  • Previous cancer

Trial design

57,053 participants in 1 patient group

The Diet, Cancer and Health cohort
Treatment:
Other: Alpha-linolenic acid

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems